Dr. Mahmoudjafari asks Dr. Murthy how he weighs frailty, comorbidities, and functional status when choosing initial treatment ...

Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, ...

The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...

Immediate DAA treatment, syringe services, and society advocacy are key to eliminating the hepatitis C virus (HCV) among people who use drugs. Eliminating hepatitis C infections and preventing ...

Ambient AI and analytics may ease clinical workloads and uncover insights, but safety, validated data, HIPAA compliance, and equity must guide adoption.

No signs of conditions that may require surgery, such as urinary obstruction or abscess ...

AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access. When managed care leaders convene in San Diego ...

A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin. Chronic hand eczema (CHE) is a debilitating dermatologic condition that often proves refractory to ...

Bronchiectasis appears to share genetic signals with chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis, and a cross-ancestry genetic analysis of more than 1.8 million people ...

Cosibelimab (UNLOXCYT; Sun Pharma) received a National Comprehensive Cancer Network (NCCN) Category 2A preferred designation for patients with locally advanced cutaneous squamous cell carcinoma (CSCC) ...

As intensive care unit (ICU) admission is rarely planned, conversations about end-of-life wishes need to happen well before a ...

The AAO 2026 annual meeting, held in New Orleans, Louisiana, from October 10 to October 12, 2026, was a weekend that provided ...